(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 28.59% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.4%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.35%.
Staar Surgical Co's revenue in 2023 is $279,348,000.On average, 3 Wall Street analysts forecast STAA's revenue for 2023 to be $17,912,882,233, with the lowest STAA revenue forecast at $17,648,326,064, and the highest STAA revenue forecast at $18,250,904,801. On average, 1 Wall Street analysts forecast STAA's revenue for 2024 to be $23,119,741,000, with the lowest STAA revenue forecast at $23,119,741,000, and the highest STAA revenue forecast at $23,119,741,000.
In 2025, STAA is forecast to generate $28,702,030,425 in revenue, with the lowest revenue forecast at $28,702,030,425 and the highest revenue forecast at $28,702,030,425.